Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhree Kim

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Annals of Surgical Oncology|June 5, 2014
Choosing a cancer surgeon: analyzing factors in patient decision making using a best-worst scaling methodologyAslam Ejaz, Gaya Spolverato, John F Bridges, et al.
Surgery|September 19, 2015
Variation in the use of type and crossmatch blood ordering among patients undergoing hepatic and pancreatic resectionsAslam Ejaz, Steven M Frank, Gaya Spolverato, et al.
Cancer|June 1, 2016
Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastasesGeorgios A Margonis, Yuhree Kim, Kazunari Sasaki, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 27, 2014
Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital chargesAslam Ejaz, Eugene Semenov, Gaya Spolverato, et al.
Annals of Surgical Oncology|June 17, 2015
Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver MetastasesGeorgios A Margonis, Gaya Spolverato, Yuhree Kim, et al.
Oncotarget|May 29, 2018
Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinomaRichard Kim, Domenico Coppola, Emilie Wang, et al.
Annals of Surgical Oncology|February 10, 2015
Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification SchemaYuhree Kim, Gaya Spolverato, Neda Amini, et al.
Journal of Surgical Oncology|June 7, 2016
Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastasesGeorgios Antonios Margonis, Yuhree Kim, Kazunari Sasaki, et al.
Communications Biology|January 5, 2024
Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinomaHélène Choquet, Chen Jiang, Jie Yin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma: A single center experienceEfstathios A Antoniou, Georgios A Margonis, Neda Amini, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|June 5, 2014
Choosing a cancer surgeon: analyzing factors in patient decision making using a best-worst scaling methodologyAslam Ejaz, Gaya Spolverato, John F Bridges, et al.
Surgery|September 19, 2015
Variation in the use of type and crossmatch blood ordering among patients undergoing hepatic and pancreatic resectionsAslam Ejaz, Steven M Frank, Gaya Spolverato, et al.
Cancer|June 1, 2016
Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastasesGeorgios A Margonis, Yuhree Kim, Kazunari Sasaki, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 27, 2014
Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital chargesAslam Ejaz, Eugene Semenov, Gaya Spolverato, et al.
Annals of Surgical Oncology|June 17, 2015
Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver MetastasesGeorgios A Margonis, Gaya Spolverato, Yuhree Kim, et al.
Oncotarget|May 29, 2018
Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinomaRichard Kim, Domenico Coppola, Emilie Wang, et al.
Annals of Surgical Oncology|February 10, 2015
Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification SchemaYuhree Kim, Gaya Spolverato, Neda Amini, et al.
Journal of Surgical Oncology|June 7, 2016
Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastasesGeorgios Antonios Margonis, Yuhree Kim, Kazunari Sasaki, et al.
Communications Biology|January 5, 2024
Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinomaHélène Choquet, Chen Jiang, Jie Yin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma: A single center experienceEfstathios A Antoniou, Georgios A Margonis, Neda Amini, et al.
Pageof 13